These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 38943996)
41. Predicting microsatellite instability and key biomarkers in colorectal cancer from H&E-stained images: achieving state-of-the-art predictive performance with fewer data using Swin Transformer. Guo B; Li X; Yang M; Jonnagaddala J; Zhang H; Xu XS J Pathol Clin Res; 2023 May; 9(3):223-235. PubMed ID: 36723384 [TBL] [Abstract][Full Text] [Related]
42. The practical utility of AI-assisted molecular profiling in the diagnosis and management of cancer of unknown primary: an updated review. Lorkowski SW; Dermawan JK; Rubin BP Virchows Arch; 2024 Feb; 484(2):369-375. PubMed ID: 37999736 [TBL] [Abstract][Full Text] [Related]
43. Optimized screening of DNA methylation sites combined with gene expression analysis to identify diagnostic markers of colorectal cancer. Ye Z; Song G; Liang J; Yi S; Gao Y; Jiang H BMC Cancer; 2023 Jul; 23(1):617. PubMed ID: 37400791 [TBL] [Abstract][Full Text] [Related]
44. Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers. Zhang YA; Ma X; Sathe A; Fujimoto J; Wistuba I; Lam S; Yatabe Y; Wang YW; Stastny V; Gao B; Larsen JE; Girard L; Liu X; Song K; Behrens C; Kalhor N; Xie Y; Zhang MQ; Minna JD; Gazdar AF J Thorac Oncol; 2016 Mar; 11(3):346-360. PubMed ID: 26725182 [TBL] [Abstract][Full Text] [Related]
45. Hypermethylation of TMEM240 predicts poor hormone therapy response and disease progression in breast cancer. Lin RK; Su CM; Lin SY; Thi Anh Thu L; Liew PL; Chen JY; Tzeng HE; Liu YR; Chang TH; Lee CY; Hung CS Mol Med; 2022 Jun; 28(1):67. PubMed ID: 35715741 [TBL] [Abstract][Full Text] [Related]
46. Development and validation of 3-CpG methylation prognostic signature based on different survival indicators for colorectal cancer. Huang H; Zhang L; Fu J; Tian T; Liu X; Liu Y; Sun H; Li D; Zhu L; Xu J; Zheng T; Jia C; Zhao Y Mol Carcinog; 2021 Jun; 60(6):403-412. PubMed ID: 33826760 [TBL] [Abstract][Full Text] [Related]
47. A suite of DNA methylation markers that can detect most common human cancers. Vrba L; Futscher BW Epigenetics; 2018; 13(1):61-72. PubMed ID: 29212414 [TBL] [Abstract][Full Text] [Related]
48. Identification of functional methylated CpG loci in PD-L1 promoter as the novel epigenetic biomarkers for primary gastric cancer. Amini M; Hejazi M; Ghorban K; Mokhtarzadeh A; Baradaran B Gene; 2021 Mar; 772():145376. PubMed ID: 33359128 [TBL] [Abstract][Full Text] [Related]
49. Identification of diagnostic DNA methylation biomarkers specific for early-stage lung adenocarcinoma. Cai Q; Zhang P; He B; Zhao Z; Zhang Y; Peng X; Xie H; Wang X Cancer Genet; 2020 Aug; 246-247():1-11. PubMed ID: 32805686 [TBL] [Abstract][Full Text] [Related]
50. Identification of DNA methylation characteristics associated with metastasis and prognosis in colorectal cancer. Qian F; Li Q; Chang H; Wei K; Chen X; Huang T; Li Y BMC Med Genomics; 2024 May; 17(1):127. PubMed ID: 38730335 [TBL] [Abstract][Full Text] [Related]
51. An integrated tool for determining the primary origin site of metastatic tumours. Santos MTD; Souza BF; Cárcano FM; Vidal RO; Scapulatempo-Neto C; Viana CR; Carvalho AL J Clin Pathol; 2018 Jul; 71(7):584-593. PubMed ID: 29248889 [TBL] [Abstract][Full Text] [Related]
52. Application of a Neural Network Whole Transcriptome-Based Pan-Cancer Method for Diagnosis of Primary and Metastatic Cancers. Grewal JK; Tessier-Cloutier B; Jones M; Gakkhar S; Ma Y; Moore R; Mungall AJ; Zhao Y; Taylor MD; Gelmon K; Lim H; Renouf D; Laskin J; Marra M; Yip S; Jones SJM JAMA Netw Open; 2019 Apr; 2(4):e192597. PubMed ID: 31026023 [TBL] [Abstract][Full Text] [Related]
53. Identification of the origin of brain metastases based on the relative methylation orderings of CpG sites. Liu H; Chen J; Chen H; Xia J; Wang O; Xie J; Li M; Guo Z; Chen G; Yan H Epigenetics; 2021 Aug; 16(8):908-916. PubMed ID: 32965167 [TBL] [Abstract][Full Text] [Related]
54. Hierarchical classification-based pan-cancer methylation analysis to classify primary cancer. Yang Y; Zeng Q; Liu G; Zheng S; Luo T; Guo Y; Tang J; Huang Y BMC Bioinformatics; 2023 Dec; 24(1):465. PubMed ID: 38066424 [TBL] [Abstract][Full Text] [Related]
55. Integrative analysis of DNA methylation and gene expression profiles identified potential breast cancer-specific diagnostic markers. Liu X; Peng Y; Wang J Biosci Rep; 2020 May; 40(5):. PubMed ID: 32412047 [TBL] [Abstract][Full Text] [Related]
56. Analysis of endometrial carcinoma TCGA reveals differences in DNA methylation in tumors from Black and White women. Asif H; Foley G; Simon M; Roque D; Kim JJ Gynecol Oncol; 2023 Mar; 170():1-10. PubMed ID: 36580834 [TBL] [Abstract][Full Text] [Related]
57. A 92-gene cancer classifier predicts the site of origin for neuroendocrine tumors. Kerr SE; Schnabel CA; Sullivan PS; Zhang Y; Huang VJ; Erlander MG; Brachtel EF; Dry SM Mod Pathol; 2014 Jan; 27(1):44-54. PubMed ID: 23846576 [TBL] [Abstract][Full Text] [Related]
58. Colon cancer-specific diagnostic and prognostic biomarkers based on genome-wide abnormal DNA methylation. Wang Y; Zhang M; Hu X; Qin W; Wu H; Wei M Aging (Albany NY); 2020 Nov; 12(22):22626-22655. PubMed ID: 33202377 [TBL] [Abstract][Full Text] [Related]
59. A multifactorial signature of DNA sequence and polycomb binding predicts aberrant CpG island methylation. McCabe MT; Lee EK; Vertino PM Cancer Res; 2009 Jan; 69(1):282-91. PubMed ID: 19118013 [TBL] [Abstract][Full Text] [Related]
60. Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: Mijnes J; Veeck J; Gaisa NT; Burghardt E; de Ruijter TC; Gostek S; Dahl E; Pfister D; Schmid SC; Knüchel R; Rose M Clin Epigenetics; 2018; 10():15. PubMed ID: 29445424 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]